• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 感染后数月的胃肠道后遗症:一项前瞻性、观察性研究。

Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study.

机构信息

Clinic of Internal Medicine- Gastroenterology, University Hospital in Martin, Jessenius Faculty of Medicine in Martin (JFM CU), Comenius University in Bratislava.

Clinic of Infectology and Travel Medicine, University Hospital in Martin, Jessenius Faculty of Medicine in Martin (JFM CU), Comenius University in Bratislava.

出版信息

Eur J Gastroenterol Hepatol. 2022 Sep 1;34(9):925-932. doi: 10.1097/MEG.0000000000002425. Epub 2022 Jul 27.

DOI:10.1097/MEG.0000000000002425
PMID:35913778
Abstract

INTRODUCTION

Post-coronavirus disease (post-COVID) symptoms arise mostly from impaired function of respiratory tract although in many patients, the dysfunction of gastrointestinal tract and liver among other organ systems may persist.

METHODS

Primary data collection was based on a short gastrointestinal symptom questionnaire at the initial screening. A brief telephone survey within the patient and control group was performed 5-8 months after the initial screening. R ver. 4.0.5 and imbalanced RandomForest (RF) machine-learning algorithm were used for data explorations and analyses.

RESULTS

A total of 590 patients were included in the study. The general presence of gastrointestinal symptoms 208.2 days (153-230 days) after the initial acute severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection was 19% in patients with moderate-to-serious course of the disease and 7.3% in patients with mild course compared with 3.0% in SARS-CoV-2 negative controls (P < 0.001). Diarrhea and abdominal pain are the most prevalent post-COVID gastrointestinal symptoms. RF machine-learning algorithm identified acute diarrhea and antibiotics administration as the strongest predictors for gastrointestinal sequelae with area under curve of 0.68. Variable importance for acute diarrhea is 0.066 and 0.058 for antibiotics administration.

CONCLUSION

The presence of gastrointestinal sequelae 7 months after the initial SARS-CoV-2 infection is significantly higher in patients with moderate-to-severe course of the acute COVID-19 compared with asymptomatic patients or those with mild course of the disease. The most prevalent post-COVID gastrointestinal symptoms are diarrhea and abdominal pain. The strongest predictors for persistence of these symptoms are antibiotics administration and acute diarrhea during the initial infection.

摘要

简介

新冠病毒病(COVID-19)后症状主要源于呼吸道功能障碍,尽管在许多患者中,胃肠道和肝脏等其他器官系统的功能障碍可能持续存在。

方法

初步数据收集基于初始筛查时的简短胃肠道症状问卷。在初始筛查后 5-8 个月,对患者和对照组进行简短的电话调查。使用 R 版本 4.0.5 和不平衡随机森林(RF)机器学习算法进行数据探索和分析。

结果

共有 590 名患者纳入研究。在初始严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染后 208.2 天(153-230 天),中度至重度疾病患者胃肠道症状的总体发生率为 19%,轻度疾病患者为 7.3%,而 SARS-CoV-2 阴性对照组为 3.0%(P<0.001)。腹泻和腹痛是 COVID-19 后最常见的胃肠道症状。RF 机器学习算法确定急性腹泻和抗生素治疗是胃肠道后遗症的最强预测因素,曲线下面积为 0.68。急性腹泻的变量重要性为 0.066,抗生素治疗为 0.058。

结论

与无症状患者或轻症患者相比,中度至重度急性 COVID-19 患者在初始 SARS-CoV-2 感染后 7 个月出现胃肠道后遗症的发生率明显更高。COVID-19 后最常见的胃肠道症状是腹泻和腹痛。这些症状持续存在的最强预测因素是初始感染期间使用抗生素和急性腹泻。

相似文献

1
Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study.严重急性呼吸综合征冠状病毒 2 感染后数月的胃肠道后遗症:一项前瞻性、观察性研究。
Eur J Gastroenterol Hepatol. 2022 Sep 1;34(9):925-932. doi: 10.1097/MEG.0000000000002425. Epub 2022 Jul 27.
2
Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission.比较 COVID-19 住院患者入院前后出现胃肠道症状的疾病进程。
Turk J Gastroenterol. 2023 Apr;34(4):322-331. doi: 10.5152/tjg.2023.22003.
3
The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?肠道微生物组:理解 COVID-19 胃肠道表现的缺失环节?
Cold Spring Harb Mol Case Stud. 2021 Apr 8;7(2). doi: 10.1101/mcs.a006031. Print 2021 Apr.
4
COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.COVID-19 肺外疾病——特殊的胃肠道和肝脏注意事项。
Dis Mon. 2020 Sep;66(9):101064. doi: 10.1016/j.disamonth.2020.101064. Epub 2020 Jul 28.
5
Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.韩国无症状和轻症 COVID-19 患者粪便样本中 SARS-CoV-2 的检测。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1387-1394.e2. doi: 10.1016/j.cgh.2020.06.005. Epub 2020 Jun 10.
6
Correlation of Gastrointestinal Symptoms at Initial Presentation with Clinical Outcomes in Hospitalized COVID-19 Patients: Results from a Large Health System in the Southern USA.美国南部某大型医疗体系中 COVID-19 住院患者初诊时胃肠道症状与临床结局的相关性:一项研究结果
Dig Dis Sci. 2022 Nov;67(11):5034-5043. doi: 10.1007/s10620-022-07384-0. Epub 2022 Feb 7.
7
Prevalence of Gastrointestinal Symptoms and Clinical Outcomes in Hospitalized Coronavirus Disease 2019 Patients: A Single-Center Study from Turkey.土耳其单中心研究:住院的 2019 年冠状病毒病患者的胃肠道症状及临床结局的流行情况。
Turk J Gastroenterol. 2022 Nov;33(11):955-963. doi: 10.5152/tjg.2022.21484.
8
Gastrointestinal symptoms in COVID-19: the long and the short of it.新型冠状病毒肺炎的胃肠道症状:长与短。
Curr Opin Gastroenterol. 2022 Nov 1;38(6):555-561. doi: 10.1097/MOG.0000000000000876. Epub 2022 Sep 9.
9
Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.SARS-CoV-2 感染后持续的胃肠道症状和感染后肠易激综合征:来自亚利桑那州 CoVHORT 的结果。
Epidemiol Infect. 2022 Jul 8;150:e136. doi: 10.1017/S0950268822001200.
10
A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization.机器学习方法用于识别与 COVID-19 相关住院风险相关的胃肠道预测因素。
PeerJ. 2022 Mar 21;10:e13124. doi: 10.7717/peerj.13124. eCollection 2022.

引用本文的文献

1
Acute gastrointestinal and post-acute COVID-19 gastrointestinal syndrome assessment on the Gastrointestinal Symptom Rating Scale scoring system: A questionnaire-based survey.基于胃肠道症状评分量表评分系统的急性胃肠道及急性后新冠病毒病胃肠道综合征评估:一项问卷调查
J Family Med Prim Care. 2024 Dec;13(12):5787-5798. doi: 10.4103/jfmpc.jfmpc_707_24. Epub 2024 Dec 9.
2
The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults.新冠后持续性症状(长新冠)负担:儿童和成人对照研究的荟萃分析。
Virol J. 2024 Jan 11;21(1):16. doi: 10.1186/s12985-024-02284-3.
3
A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.
急性 SARS-CoV-2 感染后持续性胃肠道症状的患病率和新发胃肠道疾病的发生率的系统评价。
Viruses. 2023 Jul 26;15(8):1625. doi: 10.3390/v15081625.
4
Trajectory of Gastrointestinal Symptoms in Previously Hospitalized COVID-19 Survivors: The Long COVID Experience Multicenter Study.COVID-19 幸存者住院后胃肠道症状的轨迹:长新冠多中心研究。
Viruses. 2023 May 10;15(5):1134. doi: 10.3390/v15051134.
5
Changes in the Urine Metabolomic Profile in Patients Recovering from Severe COVID-19.重症 COVID-19 康复患者尿液代谢组学特征的变化
Metabolites. 2023 Feb 28;13(3):364. doi: 10.3390/metabo13030364.
6
Explainable Artificial Intelligence in the Early Diagnosis of Gastrointestinal Disease.可解释人工智能在胃肠道疾病早期诊断中的应用
Diagnostics (Basel). 2022 Nov 9;12(11):2740. doi: 10.3390/diagnostics12112740.